Searchable abstracts of presentations at key conferences in endocrinology

ea0091cb52 | Additional Cases | SFEEU2023

Cyclical Cushing’s disease – challenges in diagnosis and management

Sawhney Natasha , Abraham Prakash

Background: The case is a 64 year old patient referred by the GP who noticed she looked ‘cushingoid’. She gave an approximately 4 year history of a change in facial complexion, central weight gain, unsteadiness and poor wound healing. There was a history of depression, essential hypertension and previous back surgery. On examination she was plethoric, had pedal oedema, thin skin and central obesity (BMI 32).Investigations: Initial overnight dex...

ea0055we2 | Workshop E: Disorders of the adrenal gland | SFEEU2018

Challenges in managing primary hyperaldosteronism

Sawhney Natasha , Graveling Alex , Abraham Prakash

Background: A 59 year old man was referred to Endocrinology from Neurology with a 2 year history of hypertension, and a 1 year history of mild hypernatraemia (146–148 mmol/l) and hypokalaemia (3.2–3.4 mmol/l). He had a past history of a cerebral aneurysm and superficial siderosis. His main complaints were severe fatigue, poor balance and tinnitus. His medications at diagnosis were Amlodipine 5 mg and Sertraline 50 mg.Investigations: Blood press...

ea0059p212 | Thyroid | SFEBES2018

Low Dose Radioiodine Therapy for Graves’ disease: comparison of outcomes following administration of different doses across two centres

Sawhney Natasha , Diaz-Ortega Carmen , Philip Sam , Gibb Fraser , Abraham Prakash , Graveling Alex

Introduction: Low dose radioiodine (LDRAI) has been used to treat benign thyroid disease for over 70 years (1). However, controversies remain about the optimal dosage to administer. The Royal College of Physicians guidelines recommend a dosage of 400–600 MBq for uncomplicated Graves’ disease (2); the dose administered varies between centres.Methods: Outcome data at Edinburgh Royal Infirmary were collected retrospectively for patients who receiv...